Business
Why the Next Science (ASX:NXS) share price is 5% higher today
The Next Science Ltd (ASX: NXS) share price is surging higher today. This comes after the company announced it has received CE mark approval for its product, BlastX. At the time of writing, the Next Science share price is up 5.04% to $1.25.
BlastX is an antimicrobial wound gel that uses the company’s biofilm-disrupting Xbio technology. BlastX works by breaking down the protective layer of biofilm and eliminating the bacteria. It then maintains a moist wound environment which allows the healing process to begin.
The product is ideal for the treatment of chronic wounds such as diabetic foot ulcers, bed sores (pressure ulcers) and venous leg ulcers. In addition, BlastX is used in operating theatre environments to help prevent…
-
Business16 hours agoHow to choose your first ASX ETF
-
Business18 hours agoAged 30 and earning an average wage? You’re now set up for retirement. Here’s how
-
Business15 hours agoHow to earn $100 a month of passive income from ASX dividends
-
Noosa News15 hours agoGelato Messina and Tony’s Chocolonely Have Collabed on a Super Gooey Bake-At-Home Cookie Pie Perfect for Cold Winter Nights